cas 2252403-82-8|| where to buy 7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

Название продукции:7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

IUPAC Name:7-chloro-6-fluoro-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-2,4-dione

: CAS：2252403-82-8; Молекулярная формула：C16H14ClFN4O2; Чистота：95%+

Упаковочная единица	Доступно для заказа	Цена ($)
CM337558-100g	in stock	ƀŴɅɅ
CM337558-500g	in stock	ɅƻȬƙ
CM337558-1000g	in stock	ƱȬȬȬ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2252403-82-8 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:2252403-82-8; Молекулярная формула:C16H14ClFN4O2; Точка плавления:-; Smiles-код:O=C1N(C2=C(C)C=CN=C2C(C)C)C3=NC(Cl)=C(F)C=C3C(N1)=O; Плотность:

: Номер в каталоге:CM337558; Молекулярная масса:348.76; Точка кипения:; Номер Mdl:; Хранение:Keep in a tight container and store at abient temperature

: Sotorasib; Dec. 26, 2023, Amgen announced that the U.S. FDA has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).
LUMAKRAS (sotorasib) is an oral, first-in-class therapy indicawithted for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) following at least one previous systemic therapy.
Sotorasib is the first approved targeted therapy for patients with tumors with any KRAS mutation, which accounts for approximately 25% of mutations in NSCLC. The U.S. FDA granted the application for sotorasib orphan drug, fast track, priority review, and breakthrough therapy designations.